From Suspicion to Specificity: Expanding the Diagnostic Lens in Infectious Disease
ASH 2026 - American Society of Hematology Annual Meeting & Exposition
The 68th ASH Annual Meeting and Exposition will take place December 12-15, 2026, in New Orleans, Louisiana, and online. Mark your calendars now to attend the world’s...
Beyond Viral Load: Understanding BKV-Specific T-Cell Immunity After Kidney Transplantation
Beyond the Patient: The Importance of Rapid Molecular Detection to Help Healthcare Facilities Stay Ahead of Candida auris
IDWeek 2026 - Infectious Disease Week October 21-24
Eurofins Viracor with be exhibiting at IDWeek 2026, booth #1719 from October 21-24 in Washington, DC...
Eurofins Viracor Launches BKV inSIGHT™ T-Cell Immunity Panel
Eurofins Viracor has launched the BKV inSIGHT™ T-Cell Immunity Panel (TCIP), a new assay that measures BK virus-specific T-cell immunity in kidney transplant patients with recent-onset BK viremia. The test provides clinicians with insight into a patient's ability to control BK virus replication, helping inform immunosuppression management and support comprehensive transplant patient monitoring.
Eurofins Viracor Expands Cytokine Testing Menu
Eurofins Viracor has launched three new plasma-based immune monitoring assays, CXCL9, CXCL10, and IL-18, for transplant and immunocompromised patients. These biomarkers provide insight into immune activation and inflammation using a minimally invasive blood sample. The tests are available with a 24-hour turnaround time and further expand Eurofins Viracor's transplant and immunology testing portfolio.
Innovation Is a Team Effort: Turning Diagnostic “Sparks” Into Clinical Impact
Providing Insights Into Cancer Treatment Success
ATC 2026 - American Transplant Congress
Eurofins Viracor will be exhibiting at ATC 2026, June 20-24, 2026, Booth #231, Thomas M. Menino Convention Center, Boston, MA
All posts
Categories
Chat With An Expert